相似文献
1
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.
J Clin Microbiol. 1992 Mar;30(3):744-5. doi: 10.1128/jcm.30.3.744-745.1992.
2
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
J Clin Microbiol. 1992 Jan;30(1):225-6. doi: 10.1128/jcm.30.1.225-226.1992.
3
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin.
J Clin Microbiol. 1992 May;30(5):1317-9. doi: 10.1128/jcm.30.5.1317-1319.1992.
4
Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzae.
Eur J Clin Microbiol Infect Dis. 1992 May;11(5):462-5. doi: 10.1007/BF01961865.
5
Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
J Clin Microbiol. 1993 Sep;31(9):2538-40. doi: 10.1128/jcm.31.9.2538-2540.1993.
6
Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
Diagn Microbiol Infect Dis. 1992 Nov-Dec;15(8):693-701. doi: 10.1016/0732-8893(92)90073-3.
7
Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium.
Diagn Microbiol Infect Dis. 1992 Feb;15(2):145-50. doi: 10.1016/0732-8893(92)90039-v.
8
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin.
J Clin Microbiol. 1992 Nov;30(11):3013-5. doi: 10.1128/jcm.30.11.3013-3015.1992.
9
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae.
Diagn Microbiol Infect Dis. 2003 Jun;46(2):147-50. doi: 10.1016/s0732-8893(03)00039-7.
10
Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters.
J Clin Microbiol. 1993 Sep;31(9):2375-80. doi: 10.1128/jcm.31.9.2375-2380.1993.
引用本文的文献
1
Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
J Clin Microbiol. 1993 Sep;31(9):2538-40. doi: 10.1128/jcm.31.9.2538-2540.1993.
2
Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzae.
Eur J Clin Microbiol Infect Dis. 1992 May;11(5):462-5. doi: 10.1007/BF01961865.
本文引用的文献
1
Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.
J Clin Microbiol. 1981 Jul;14(1):67-72. doi: 10.1128/jcm.14.1.67-72.1981.
2
Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.
J Clin Microbiol. 1987 Nov;25(11):2105-13. doi: 10.1128/jcm.25.11.2105-2113.1987.
3
Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.
Antimicrob Agents Chemother. 1987 Nov;31(11):1768-74. doi: 10.1128/AAC.31.11.1768.
4
In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.
Antimicrob Agents Chemother. 1986 Jun;29(6):1059-66. doi: 10.1128/AAC.29.6.1059.
5
Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.
Antimicrob Agents Chemother. 1989 Oct;33(10):1795-800. doi: 10.1128/AAC.33.10.1795.
6
Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests.
Antimicrob Agents Chemother. 1989 Apr;33(4):569-72. doi: 10.1128/AAC.33.4.569.
7
Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium.
Diagn Microbiol Infect Dis. 1991 Nov-Dec;14(6):485-93. doi: 10.1016/0732-8893(91)90004-y.
8
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.
Diagn Microbiol Infect Dis. 1991 Sep-Oct;14(5):389-401. doi: 10.1016/0732-8893(91)90066-o.
9
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
J Clin Microbiol. 1992 Jan;30(1):225-6. doi: 10.1128/jcm.30.1.225-226.1992.
Zotero 插件